NYSE:SNN

Smith & Nephew PLC (SNN)

30.18
-0.26 (0.84%)
as of Jul 21, 2026, 7:21:01 pm Market Open.
33 watching
0
Investor Insights
star iconJul 21, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Smith & Nephew PLC (SNN-N) has been positively reviewed by experts due to its recent turnaround and improved financial metrics under new management. The company offers a range of orthopedic services, including joint repairs and dressings, and has gained significant brand recognition in the market. Analysts note that SNN-N is trading at only half the valuation of its larger competitor, Stryker, while exhibiting similar profitability margins. This gap suggests a substantial potential for price appreciation as the company continues to show operational improvements and benefits from industry growth. With a favorable aggregate rating from analysts, there seems to be a strong bullish sentiment surrounding SNN-N's future performance.

consensus icon
Consensus
Buy
valuation icon
Valuation
Undervalued
review icon
Similar
SYK
TOP PICK
1% dividend and 1% negative growth last year are because of acquisitions. 30 X earnings can be sustained.
Showing 46 to 46 of 46 entries